Trial Profile
Study assessing safety of clopidogrel, prasugrel and ticagrelor
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2017
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions
- 02 Feb 2017 New trial record